BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease

被引：0
|
作者：
Poewe, W.
Kieburtz, K.
Stocchi, F.
Oren, S.
Yardeni, T.
Adar, L.
Rosenfeld, O.
Olanow, C.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
179
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] BouNDless: Study Design of an Active-Controlled, Randomized, Double-Blind Double-Dummy Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease and Motor Fluctuations
    Espay, A.
    Kieburtz, K.
    Olanow, C. W.
    Case, R.
    Yardeni, T.
    Sasson, N.
    Adar, L.
    Rascol, O.
    MOVEMENT DISORDERS, 2022, 37 : S8 - S8
  • [2] BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Barak, S. Leibman
    Adar, L.
    Rosenfeld, O.
    Olanow, C. W.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E53 - E53
  • [3] The BouNDless Study: An Active-Controlled, Randomized, Double-Blind, Double-Dummy Phase 3 Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease Experiencing Motor Fluctuations
    Espay, Alberto
    Rascol, Olivier
    Yardeni, Tamar
    Adar, Liat
    Rosenfeld, Olivia
    Case, Ryan
    Olanow, C. Warren
    NEUROLOGY, 2020, 94 (15)
  • [4] BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease experiencing motor complications
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Rosenfeld, O.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1105 - 1105
  • [5] ND0612 infusion in fluctuating Parkinson's disease: a randomised, double-blind, placebo-controlled study
    Stocchi, F.
    Lewitt, P.
    Isaacson, S.
    Leionen, M.
    Minei, T. Rachmilewitz
    Oren, S.
    Kieburtz, K.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 515 - 515
  • [6] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05): : 465 - 476
  • [7] iNDiGO: A Multicenter, Randomized, Double-blind, Placebo-controlled, Study of Continuous ND0612 Infusion with Adjunct Oral Levodopa in Fluctuating Parkinson's Disease
    LeWitt, Peter
    Stocchi, Fabrizio
    Isaacson, Stuart
    Leionen, Mika
    Rachmilewitz, Tami
    Case, Ryan
    Kieburtz, Karl
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2018, 33 : S94 - S94
  • [8] CONTINUOUS SUBCUTANEOUS LEVODOPA/CARBIDOPA INFUSION (ND0612) FOR PATIENTS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS: A PHASE 3, ACTIVE-CONTROLLED STUDY (BOUNDLESS)
    Stocchi, F.
    Espay, A.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J. J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Yardeni, T.
    Adar, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Rascol, O.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [9] Continuous Subcutaneous Levodopa/Carbidopa Infusion With ND0612 For Patients With Parkinson's Disease And Motor Fluctuations: Results From The Phase 3 Randomized, Active-Controlled BouNDless Study
    Rascol, O.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Salin, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Espay, A.
    MOVEMENT DISORDERS, 2023, 38 : S4 - S4
  • [10] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (vol 43, pg 465, 2024)
    Espay, A. J.
    Stocchi, F.
    Pahwa, R.
    LANCET NEUROLOGY, 2024, 23 (06): : E10 - E10
12345